Skip to main content
. 2021 Aug 30;12:737630. doi: 10.3389/fphar.2021.737630

FIGURE 4.

FIGURE 4

Potential metabolites changes in ANIT-induced cholestatic liver injury with PF treatment. (A) 3-Methoxytyramine; (B) 5-L-Glutamyl-taurine; (C) Homovanillic acid; (D) UDP-D-Xylose; (E) L-Dopa; (F) Linoleic acid; (G) L-Phenylalanine; (H) N-Desmethylcitalopram; (I) PE [15:0/18:4 (6Z,9Z,12Z,15Z)]; (J) Phosphocreatine; (K) Sepiapterin; (L) Taurochenodesoxycholic acid. Data were presented as means ± SD (n = 6). ## p < 0.01, # p < 0.05 compared with the control group, ** p < 0.01, * p < 0.05 compared with ANIT group.